A citation-based method for searching scientific literature

Melinda L Yushak, Gang Han, Sara Bouberhan, Lianne Epstein, Michael P DiGiovanna, Sarah S Mougalian, Tara B Sanft, Maysa M Abu-Khalaf, Gina G Chung, Stacey M Stein, Sarah B Goldberg, Lajos Pusztai, Erin W Hofstatter. Cancer 2016
Times Cited: 34







List of co-cited articles
164 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
41

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
902
29


Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
82
23

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
325
23

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

Attitudes toward molecular testing for personalized cancer therapy.
Rafeek A Yusuf, Deevakar Rogith, Shelly R A Hovick, Susan K Peterson, Allison M Burton-Chase, Bryan M Fellman, Yisheng Li, Carolyn McKinney, Elmer V Bernstam, Funda Meric-Bernstam. Cancer 2015
39
20

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
76
20


Managing incidental findings in human subjects research: analysis and recommendations.
Susan M Wolf, Frances P Lawrenz, Charles A Nelson, Jeffrey P Kahn, Mildred K Cho, Ellen Wright Clayton, Joel G Fletcher, Michael K Georgieff, Dale Hammerschmidt, Kathy Hudson,[...]. J Law Med Ethics 2008
474
17

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
65
17

Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age.
K A Kaphingst, J Ivanovich, B B Biesecker, R Dresser, J Seo, L G Dressler, P J Goodfellow, M S Goodman. Clin Genet 2016
29
20

Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.
Jada G Hamilton, Elyse Shuk, Margaux C Genoff, Vivian M Rodríguez, Jennifer L Hay, Kenneth Offit, Mark E Robson. J Oncol Pract 2017
20
30

Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing.
Rhodé M Bijlsma, Hester Wessels, Roel H P Wouters, Anne M May, Margreet G E M Ausems, Emile E Voest, Annelien L Bredenoord. Fam Cancer 2018
12
50

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet Med 2013
218
14

Patients' views on incidental findings from clinical exome sequencing.
Kristin E Clift, Colin M E Halverson, Alexander S Fiksdal, Ashok Kumbamu, Richard R Sharp, Jennifer B McCormick. Appl Transl Genom 2015
61
14

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
184
14

Genomic testing in cancer: patient knowledge, attitudes, and expectations.
Phillip S Blanchette, Anna Spreafico, Fiona A Miller, Kelvin Chan, Jessica Bytautas, Steve Kang, Philippe L Bedard, Andrea Eisen, Larissa Potanina, Jack Holland,[...]. Cancer 2014
58
14

Molecular findings among patients referred for clinical whole-exome sequencing.
Yaping Yang, Donna M Muzny, Fan Xia, Zhiyv Niu, Richard Person, Yan Ding, Patricia Ward, Alicia Braxton, Min Wang, Christian Buhay,[...]. JAMA 2014
846
11

Clinical interpretation and implications of whole-genome sequencing.
Frederick E Dewey, Megan E Grove, Cuiping Pan, Benjamin A Goldstein, Jonathan A Bernstein, Hassan Chaib, Jason D Merker, Rachel L Goldfeder, Gregory M Enns, Sean P David,[...]. JAMA 2014
302
11

Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
Layla Shahmirzadi, Elizabeth C Chao, Erika Palmaer, Melissa C Parra, Sha Tang, Kelly D Farwell Gonzalez. Genet Med 2014
75
11




"I want to know what's in Pandora's Box": comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing.
Anne Townsend, Shelin Adam, Patricia H Birch, Zoe Lohn, Francois Rousseau, Jan M Friedman. Am J Med Genet A 2012
122
11

Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study.
Flavia M Facio, Haley Eidem, Tyler Fisher, Stephanie Brooks, Amy Linn, Kimberly A Kaphingst, Leslie G Biesecker, Barbara B Biesecker. Eur J Hum Genet 2013
127
11

Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.
Kelly Hitch, Galen Joseph, Jenna Guiltinan, Jessica Kianmahd, Janey Youngblom, Amie Blanco. J Genet Couns 2014
46
11

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
219
11

Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
F Meric-Bernstam, L Brusco, M Daniels, C Wathoo, A M Bailey, L Strong, K Shaw, K Lu, Y Qi, H Zhao,[...]. Ann Oncol 2016
93
11

Tumor genome analysis includes germline genome: are we ready for surprises?
Daniel V T Catenacci, Andrea L Amico, Sarah M Nielsen, Daniel M Geynisman, Brittany Rambo, George B Carey, Cassandra Gulden, Jim Fackenthal, Robert D Marsh, Hedy L Kindler,[...]. Int J Cancer 2015
56
11

Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics.
Carla G van El, Martina C Cornel, Pascal Borry, Ros J Hastings, Florence Fellmann, Shirley V Hodgson, Heidi C Howard, Anne Cambon-Thomsen, Bartha M Knoppers, Hanne Meijers-Heijboer,[...]. Eur J Hum Genet 2013
214
11

Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
Anna Middleton, Katherine I Morley, Eugene Bragin, Helen V Firth, Matthew E Hurles, Caroline F Wright, Michael Parker. Eur J Hum Genet 2016
114
11

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat Med 2017
11

Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Michael P Mackley, Benjamin Fletcher, Michael Parker, Hugh Watkins, Elizabeth Ormondroyd. Genet Med 2017
73
11

Patient perspectives on molecular tumor profiling: "Why wouldn't you?"
Megan C Best, Nicole Bartley, Chris Jacobs, Ilona Juraskova, David Goldstein, Ainsley J Newson, Jacqueline Savard, Bettina Meiser, Mandy Ballinger, Christine Napier,[...]. BMC Cancer 2019
15
26

Actionable, pathogenic incidental findings in 1,000 participants' exomes.
Michael O Dorschner, Laura M Amendola, Emily H Turner, Peggy D Robertson, Brian H Shirts, Carlos J Gallego, Robin L Bennett, Kelly L Jones, Mari J Tokita, James T Bennett,[...]. Am J Hum Genet 2013
275
8



Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Donavan T Cheng, Talia N Mitchell, Ahmet Zehir, Ronak H Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen H Won, Sasinya N Scott,[...]. J Mol Diagn 2015
8



Personalized genomic analyses for cancer mutation discovery and interpretation.
Siân Jones, Valsamo Anagnostou, Karli Lytle, Sonya Parpart-Li, Monica Nesselbush, David R Riley, Manish Shukla, Bryan Chesnick, Maura Kadan, Eniko Papp,[...]. Sci Transl Med 2015
252
8


Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).
Caroline Savage Bennette, Susan Brown Trinidad, Stephanie M Fullerton, Donald Patrick, Laura Amendola, Wylie Burke, Fuki M Hisama, Gail P Jarvik, Dean A Regier, David L Veenstra. Genet Med 2013
57
8

Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.
Dean A Regier, Stuart J Peacock, Reka Pataky, Kimberly van der Hoek, Gail P Jarvik, Jeffrey Hoch, David Veenstra. CMAJ 2015
54
8

Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq project.
Saskia C Sanderson, Michael D Linderman, Sabrina A Suckiel, Randi Zinberg, Melissa Wasserstein, Andrew Kasarskis, George A Diaz, Eric E Schadt. Eur J Hum Genet 2017
38
8

Diagnostic clinical genome and exome sequencing.
Leslie G Biesecker, Robert C Green. N Engl J Med 2014
353
8

Attitudes of African Americans toward return of results from exome and whole genome sequencing.
Joon-Ho Yu, Julia Crouch, Seema M Jamal, Holly K Tabor, Michael J Bamshad. Am J Med Genet A 2013
58
8


Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
Bryce A Seifert, Julianne M O'Daniel, Krunal Amin, Daniel S Marchuk, Nirali M Patel, Joel S Parker, Alan P Hoyle, Lisle E Mose, Andrew Marron, Michele C Hayward,[...]. Clin Cancer Res 2016
45
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.